Two Sigma Investments’s NEVRO CORP. NVRO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-8,500
Closed -$689K 4577
2021
Q4
$689K Buy
8,500
+6,100
+254% +$611K ﹤0.01% 2920
2021
Q3
$279K Sell
2,400
-1,500
-38% -$196K ﹤0.01% 3726
2021
Q2
$647K Buy
+3,900
New +$609K ﹤0.01% 2878
2020
Q3
Sell
-5,400
Closed -$645K 3647
2020
Q2
$645K Buy
+5,400
New +$640K ﹤0.01% 1831
2019
Q4
Sell
-3,400
Closed -$292K 4050
2019
Q3
$292K Sell
3,400
-6,700
-66% -$507K ﹤0.01% 2984
2019
Q2
$655K Buy
+10,100
New +$629K ﹤0.01% 2289
2018
Q3
Sell
-6,900
Closed -$551K 3678
2018
Q2
$551K Sell
6,900
-1,100
-14% -$91.2K ﹤0.01% 2581
2018
Q1
$693K Buy
+8,000
New +$646K ﹤0.01% 2258

Other funds holding NVRO

Two Sigma Investments's NVRO Position: Q2 2025 in Review

Two Sigma Investments sold out of NEVRO CORP. (NVRO) in Q2 2025, closing a stake of 330,902 shares — an estimated $1.93M sold.

Two Sigma Investments first reported a position in NVRO in Q2 2015 and held it in 26 quarters. The position peaked at $33.5M in Q4 2021. 1 fund tracked by Wall St. Rank holds NVRO as of Q2 2025.

  • Two Sigma Investments reported no remaining NEVRO CORP. position as of Q2 2025 after selling out during the quarter.
  • Two Sigma Investments sold 330,902 NEVRO CORP. shares in Q2 2025, an estimated $1.93M.
  • Two Sigma Investments first reported a position in NEVRO CORP. in Q2 2015 and held it in 26 quarters.
  • Two Sigma Investments's NEVRO CORP. position peaked at $33.5M in Q4 2021.
  • 1 fund tracked by Wall St. Rank held NEVRO CORP. as of Q2 2025.

Based on Two Sigma Investments's 13F filing for Q2 2025, filed 14 Aug 2025.